|
...diabetes achieve tight targets can be a challenging process: involving prescribing combinations of hypoglycaemic agents; negotiating side effects with patients; and trying to ensure adherence to increasingly complex regimens. Against this background, the imminent availability of newer hypoglycaemic agents is both welcome in expanding our therapeutic armamentarium, but also adds a further layer of complexity to already challenging prescribing scenarios.
[ILLUSTRATION OMITTED]
This issue of Diabetes & Primary Care includes clear descriptions...
NOTE: All illustrations and photos
have been removed from this article.
More articles from Diabetes and Primary Care
When to consider antiobesity drugs or bariatric surgery., June 22, 2007
A spoonful of education helps the medicine go down., June 22, 2007
Diabetes specialism: interesting times?(GPSI Focus), June 22, 2007
The changing face of diabetes specialist services: making it work.(GPS..., June 22, 2007
The first national conference for intermediate diabetes care teams--wi..., June 22, 2007
Looking for additional articles?
Search our database of over 3 million articles.
Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication
name or publication date.
About Goliath
Whether you're looking for sales prospects, competitive information, company
analysis or best practices in managing your organization,
Goliath can help you meet your business needs.
Our extensive business information databases empower business
professionals with both the breadth and depth of credible,
authoritative information they need to support their business
goals. Whether it be strategic planning, sales prospecting,
company research or defining management best practices -
Goliath is your leading source for accurate information.
|
